Novitium Pharma is now part of ANI Pharmaceuticals. READ MORE >

Naproxen Delayed-Release Tablets, USP

Dosage Form


Return Goods Policy

Naproxen Delayed-Release Tablets, USP

Compare To: EC-Naprosyn® Full Prescribing Information
Medication Guide
Active Ingredients: Naproxen, USP
 
To report an Adverse Event for this product, please call 1-855-204-1431 or email inquiries@novitiumpharma.com. Adverse Events may also be reported to the FDA at 1-800-FDA-1088 or www.fda.gov/medwatch.
Strength: 375 mg
Description: White to off-white, enteric coated, capsule shaped, biconvex tablets, debossed with “N11” on one side and plain on other side
Size and NDC: 100s | 70954-925-10
Strength: 500 mg
Description: White to off-white, enteric coated, capsule shaped, biconvex tablets, debossed with “N1” on one side and plain on other side
Size and NDC: 100s | 70954-928-10




All Products Available in the US

To find out more information about one of our quality pharmaceutical products, you can search or look up your product name in the alphabetized list.